RECO Flow Restoration Device Versus Solitaire FR With the Intention for Thrombectomy Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 130 participants.

Also called NCT01983644

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 130 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01983644
Other papers using this trial's data
  • RECO Flow Restoration Device Versus Solitaire FR With the Intention for Thrombectomy Study (REDIRECT): a prospective randomized controlled trial Journal of neurosurgery, 2021-05-01 DOI, PubMed 32502991

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01983644. Randomized; no masking; primary purpose treatment. Start 2013-09 (registry gives no type); primary completion 2017-12 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
RECO Flow Restoration Device Versus Solitaire FR With the Intention for Thrombectomy Study
Acronym
REDIRECT
Intervention (Device)
RECO flow restoration device
Intervention (Device)
Solitaire FR flow restoration device
Lead sponsor
Jinling Hospital, China (class: other)

Record details

Record id
cardio:ct-nct01983644
Content hash
af261a66295e8422fd830bf7a66b6a14d07b5801a344d412bc457a32db663c83